861 results on '"Privitera G"'
Search Results
2. Best practice approach to the risk management of Legionella infection in health care facilities
3. Trends in hospital acquired New Delhi metallo-beta-lactamase-producing Enterobacterales in Tuscany (Italy) from 2019 to 2021: impact of the COVID-19 pandemic
4. POS1172 PLASMA STREM1 AND IL-6 DETERMINATION IDENTIFY DISTINCT SUBSETS AND IMPROVE CLINICAL MANAGEMENT IN SPONDYLOARTHRITIS: A CROSS-SECTIONAL STUDY
5. OC.07.8: THE POCER INDEX: APPLICATION OF A NOVEL ENDOSCOPIC SCORE IN A REAL-LIFE COHORT OF PATIENTS WITH CROHN'S DISEASE AFTER SURGERY
6. Transport Conductivity of Graphene at RF and Microwave Frequencies
7. P715 Multiparametric assessment of IBD and SpA-IBD patients to explore disease biomarkers and response predictors
8. P460 The POCER index: application of a novel endoscopic score in a real-life cohort of patients with Crohn's disease after surgery
9. P1062 Effectiveness and safety outcomes beyond five years of IBD patients treated with vedolizumab. The LONG-LIVE IG-IBD study
10. Non-detection of magnetic fields in the central stars of the planetary nebulae NGC 1360 and LSS 1362
11. Brownian Motion of Graphene
12. Graphene Mode-Locked Ultrafast Laser
13. Electrostatic force microscopy and potentiometry of realistic nanostructured systems
14. Artificial Intelligence Chatbots for medical training in Public Health: a tool to explore
15. Tunnelling times: An elementary introduction
16. POS0441 SPONDYLOARTHRITIS IMMUNOLOGICAL AND TISSUES FEATURES DIFFER ACCORDING TO THE COHEXISTING INFLAMMATORY BOWEL DISEASE: A CROSS-SECTIONAL STUDY
17. PC.01.2 IL-33 ACTIVATES CD73-EXPRESSING CELLS PROMOTING TUMORIGENESIS DURING COLITIS-ASSOCIATED COLORECTAL CANCER
18. OC.10.5 ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
19. P099 IL-33 activates CD73-expressing cells promoting tumorigenesis during colitis-associated colorectal cancer
20. P455 Comparison of two strategies for the management of post-operative recurrence in Crohn’s disease patients with one clinical risk factor: a multicentre IG-IBD study
21. Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases
22. Need for a competency-based approach for the Public Health Workforce training: the ISS proposal
23. Flu vaccination coverage in healthcare workers during a 3-year period in the context of the pandemic
24. Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study
25. News and Views in Uva-Laser–Induced Ultraweak Delayed Luminescence of Cultured Mammalian Cells
26. In vitro antiproliferative effect of trastuzumab (Herceptin®) combined with cetuximab (Erbitux®) in a model of human non-small cell lung cancer expressing EGFR and HER2
27. OC.17.4 COMBINATION OF ADVANCED THERAPIES IN PATIENTS WITH COMPLEX INFLAMMATORY BOWEL DISEASE
28. The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications
29. Analysis of High-Speed Logic Families
30. Novel Insights Into the Interactions Between the Gut Microbiome, Inflammasomes, and Gasdermins During Colorectal Cancer
31. The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic
32. LE VITTORIE DEI BASSIDI NELLA SESTA NEMEA DI PINDARO
33. GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis
34. Igiene, Medicina Preventiva, Sanità Pubblica
35. Hebe nella settima Nemea di Pindaro
36. Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease
37. 'My body is out to wreck everything I have': A qualitative study of how women with endometriosis feel about their bodies
38. Digital devices to assess vaccine hesitancy and promote pertussis vaccination during pregnancy
39. OC.09.1 THE MODERATING EFFECT OF RESILIENCE ON DEPRESSION IN PATIENTS WITH CROHN’S DISEASE
40. OC.09.3 EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN A MATCHED COHORT OF ELDERLY AND YOUNG IBD PATIENTS: IG IBD LIVE STUDY GROUP
41. Assessment, control, and prevention of microbiological and chemical hazards in seasonal swimming pools of the Versilia district (Tuscany, central Italy)
42. Tre Note Alla Prima Nemea
43. Saffo Fr. 31,13 L.-P.
44. DOP49 Effectiveness and safety of vedolizumab in a matched cohort of elderly and young Inflammatory Bowel Disease patients - LIVE Study-Group
45. Serum triiodothyronine-to-thyroxine (T3/T4) ratio predicts therapeutic outcome to biological therapies in elderly IBD patients
46. Two years Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD study
47. Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients
48. The educational role of IBD nurses in Italy in vaccinations: do not miss the moment for COVID-19
49. Morbidly Obese Patient With Ulcerative Colitis Treated With Endoscopic Gastroplasty: A Case Report
50. Predictors and early markers of response to biological therapies in inflammatory bowel diseases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.